Carfilzomib and dexamethasone vs bortezomib and dexamethasone in patients with relapsed multiple myeloma: results of the phase 3 study ENDEAVOR (NCT01568866) according to age subgroup. uri icon

Overview

publication date

  • March 17, 2017

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Multiple Myeloma
  • Neoplasm Recurrence, Local

Identity

Scopus Document Identifier

  • 85015635745

Digital Object Identifier (DOI)

  • 10.1080/10428194.2017.1298755

PubMed ID

  • 28306371

Additional Document Info

volume

  • 58

issue

  • 10